This Article Full Text Full Text (PDF) All Versions of this Article: 90/3/1434    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Côté, M. Articles by Després, J.-P. Search for Related Content PubMed PubMed Citation Articles by Côté, M. Articles by Després, J.-P. Related Collections Lipid Obesity

Adiponectinemia in Visceral Obesity: Impact on Glucose Tolerance and Plasma Lipoprotein and Lipid Levels in Men

Québec Heart Institute (M.C., N.A., I.L., J.-P.D.), Laval Hospital Research Center, Ste-Foy, Québec, Canada G1V 4G5; Department of Food Sciences and Nutrition (M.C., N.A.); Division of Kinesiology (P.M., A.T., J.-P.D.), Department of Social and Preventive Medicine; and Institute on Nutraceuticals and Functional Foods (A.T.), Laval University, Ste-Foy, Québec, Canada G1K 7P4; and Lipid Research Center (J.B.), CHUL Research Center, Ste-Foy, Québec, Canada G1V 4G2

Address all correspondence and requests for reprints to: Jean-Pierre Després, Ph.D., FAHA, Québec Heart Institute, Laval Hospital Research Center, 2725, chemin Ste-Foy, Pavilion Marguerite-D’Youville, 4th Floor, Ste-Foy, Québec, Canada G1V 4G5. E-mail: jean-pierre.despres{at}crhl.ulaval.ca.

The present study examined the associations between a major adipokine, adiponectin, and adiposity indices as well as metabolic risk variables in a sample of 190 untreated asymptomatic men. Anthropometric measurements and a complete fasting plasma lipoprotein and lipid profile were obtained, and subjects underwent an oral glucose tolerance test. Fasting plasma adiponectin concentrations were determined by an ELISA. Although all adiposity and adipose tissue (AT) distribution indices were negatively correlated with plasma adiponectin levels (–0.14 r –0.32; P < 0.04), multiple regression analyses revealed that visceral AT accumulation was the only independent predictor of adiponectin levels, with 10% of its variance explained by visceral AT (P < 0.0001). Comparison of obese men with similar body mass index values (30 kg/m²) but who markedly differed in their level of visceral AT (< vs. 130 cm²; n = 15) revealed significant differences in adiponectin levels (7.0 ± 3.0 vs. 11.1 ± 4.9 µg/ml; P < 0.02 for men with high vs. low visceral AT, respectively). Finally, when men were stratified into tertiles of visceral AT and further classified on the basis of the 50th percentile of adiponectin levels ( vs. >8.8 µg/ml), a 3 x 2 ANOVA revealed an independent contribution of adiponectin on the variation of high-density lipoprotein cholesterol levels (P < 0.002) and of the glucose area (P < 0.02). These results support the notion that adiponectin concentration is influenced to a greater extent by visceral than sc obesity. Furthermore, adiponectin predicts glucose tolerance and plasma high-density lipoprotein cholesterol levels in a manner that is partly independent from the contribution of visceral adiposity.

This article has been cited by other articles:

				R. Ness-Abramof and C. M. Apovian Waist Circumference Measurement in Clinical Practice Nutr Clin Pract, August 1, 2008; 23(4): 397 - 404. [Abstract] [Full Text] [PDF]

				A. B. Thrush, G. J. Heigenhauser, K. L. Mullen, D. C. Wright, and D. J. Dyck Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1205 - R1212. [Abstract] [Full Text] [PDF]

				J.-P. Despres and H. B. Brewer Metabolic syndrome: the dysmetabolic state of dysfunctional adipose tissue and insulin resistance Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B1 - B3. [Full Text] [PDF]

				J.-P. Despres, P. Poirier, J. Bergeron, A. Tremblay, I. Lemieux, and N. Almeras From individual risk factors and the metabolic syndrome to global cardiometabolic risk Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B24 - B33. [Abstract] [Full Text] [PDF]

				R. W. Nesto and K. Mackie Endocannabinoid system and its implications for obesity and cardiometabolic risk Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B34 - B41. [Abstract] [Full Text] [PDF]

				L. A. Kosmiski, P. Bacchetti, D. P. Kotler, S. B. Heymsfield, C. E. Lewis, M. G. Shlipak, R. Scherzer, and C. Grunfeld Relationship of Fat Distribution with Adipokines in Human Immunodeficiency Virus Infection J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 216 - 224. [Abstract] [Full Text] [PDF]

				N. Echahidi, P. Pibarot, J.-P. Despres, J.-M. Daigle, D. Mohty, P. Voisine, R. Baillot, and P. Mathieu Metabolic Syndrome Increases Operative Mortality in Patients Undergoing Coronary Artery Bypass Grafting Surgery J. Am. Coll. Cardiol., August 28, 2007; 50(9): 843 - 851. [Abstract] [Full Text] [PDF]

				A. J. G. Hanley, D. Bowden, L. E. Wagenknecht, A. Balasubramanyam, C. Langfeld, M. F. Saad, J. I. Rotter, X. Guo, Y.-D. I. Chen, M. Bryer-Ash, et al. Associations of Adiponectin with Body Fat Distribution and Insulin Sensitivity in Nondiabetic Hispanics and African-Americans J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2665 - 2671. [Abstract] [Full Text] [PDF]

				L. Fontana, J. C. Eagon, M. E. Trujillo, P. E. Scherer, and S. Klein Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans Diabetes, April 1, 2007; 56(4): 1010 - 1013. [Abstract] [Full Text] [PDF]

				K. Kantartzis, K. Rittig, B. Balletshofer, J. Machann, F. Schick, K. Porubska, A. Fritsche, H.-U. Haring, and N. Stefan The Relationships of Plasma Adiponectin with a Favorable Lipid Profile, Decreased Inflammation, and Less Ectopic Fat Accumulation Depend on Adiposity Clin. Chem., October 1, 2006; 52(10): 1934 - 1942. [Abstract] [Full Text] [PDF]

				I. Matias, M.-P. Gonthier, P. Orlando, V. Martiadis, L. De Petrocellis, C. Cervino, S. Petrosino, L. Hoareau, F. Festy, R. Pasquali, et al. Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and {beta}-Pancreatic Cells and in Obesity and Hyperglycemia J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3171 - 3180. [Abstract] [Full Text] [PDF]

				M.-H. Gannage-Yared, S. Khalife, M. Semaan, F. Fares, S. Jambart, and G. Halaby Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur. J. Endocrinol., July 1, 2006; 155(1): 167 - 176. [Abstract] [Full Text] [PDF]

				M. Briand, I. Lemieux, J. G. Dumesnil, P. Mathieu, A. Cartier, J.-P. Despres, M. Arsenault, J. Couet, and P. Pibarot Metabolic Syndrome Negatively Influences Disease Progression and Prognosis in Aortic Stenosis J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2229 - 2236. [Abstract] [Full Text] [PDF]

				N. Bansal, V. Charlton-Menys, P. Pemberton, P. McElduff, J. Oldroyd, A. Vyas, A. Koudsi, P. E. Clayton, J. K. Cruickshank, and P. N. Durrington Adiponectin in Umbilical Cord Blood Is Inversely Related to Low-Density Lipoprotein Cholesterol But Not Ethnicity J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2244 - 2249. [Abstract] [Full Text] [PDF]

				B. Verges, J. M. Petit, L. Duvillard, G. Dautin, E. Florentin, F. Galland, and P. Gambert Adiponectin Is an Important Determinant of ApoA-I Catabolism Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1364 - 1369. [Abstract] [Full Text] [PDF]

				B. Buemann, A. Astrup, O. Pedersen, E. Black, C. Holst, S. Toubro, S. Echwald, J. J. Holst, C. Rasmussen, and T. I. A. Sorensen Possible Role of Adiponectin and Insulin Sensitivity in Mediating the Favorable Effects of Lower Body Fat Mass on Blood Lipids J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1698 - 1704. [Abstract] [Full Text] [PDF]

				K. K. Ong, J. Frystyk, A. Flyvbjerg, C. J. Petry, the Avon Longitudinal Study of Parents and Childre, A. Ness, and D. B. Dunger Sex-Discordant Associations With Adiponectin Levels and Lipid Profiles in Children. Diabetes, May 1, 2006; 55(5): 1337 - 1341. [Abstract] [Full Text] [PDF]

				J.-P. Despres Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk Eur. Heart J. Suppl., May 1, 2006; 8(suppl_B): B4 - B12. [Abstract] [Full Text] [PDF]

				S. Lee, F. Bacha, N. Gungor, and S. A. Arslanian Racial Differences in Adiponectin in Youth: Relationship to visceral fat and insulin sensitivityv Diabetes Care, January 1, 2006; 29(1): 51 - 56. [Abstract] [Full Text] [PDF]

				M. A. Sabin, J. M. P. Holly, J. P. H. Shield, S. J. Turner, M. J. Grohmann, C. E. H. Stewart, and E. C. Crowne Mature Subcutaneous and Visceral Adipocyte Concentrations of Adiponectin Are Highly Correlated in Prepubertal Children and Inversely Related to Body Mass Index Standard Deviation Score J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 332 - 335. [Abstract] [Full Text] [PDF]

				N. Rasouli, A. Yao-Borengasser, L. M. Miles, S. C. Elbein, and P. A. Kern Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E42 - E46. [Abstract] [Full Text] [PDF]

				J.-P. Despres, A. Golay, L. Sjostrom, and the Rimonabant in Obesity-Lipids Study Group Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia N. Engl. J. Med., November 17, 2005; 353(20): 2121 - 2134. [Abstract] [Full Text] [PDF]

				Z. T. Bloomgarden Inflammation, Atherosclerosis, and Aspects of Insulin Action Diabetes Care, September 1, 2005; 28(9): 2312 - 2319. [Full Text] [PDF]